Literature DB >> 28583795

Measuring value and benefit-a matter of perspective.

William Kenneth Evans1, Matthew C Cheung2, Kelvin K-W Chan2.   

Abstract

Mesh:

Year:  2017        PMID: 28583795     DOI: 10.1016/S1470-2045(17)30423-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Impact of a novel prioritization framework on clinician-led oncology drug submissions.

Authors:  J Keech; J Beca; A Eisen; E Kennedy; J Kim; C T Kouroukis; G Darling; S E Ferguson; A Finelli; T M Petrella; J R Perry; K Chan; S Gavura
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

Review 2.  Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?

Authors:  Syril D Pettit; Rebecca Kirch
Journal:  Cardiooncology       Date:  2018-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.